{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:37:41Z","timestamp":1761896261008},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.oftal.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T09:17:05Z","timestamp":1458724625000},"page":"599-603","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Espironolactona, alternativa terap\u00e9utica en el tratamiento de la epiteliopat\u00eda difusa cr\u00f3nica"],"prefix":"10.1016","volume":"91","author":[{"given":"D.","family":"\u00c1ngel-Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rocha-Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cordov\u00e9s-Dorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Losada Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blasco Alberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Abreu Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2016.02.007_bib0055","first-page":"35","article-title":"Epitelopat\u00eda en Reguero","volume":"78","author":"Gismero","year":"2003","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.oftal.2016.02.007_bib0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oftal.2016.02.007_bib0065","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2147\/OPTH.S86778","article-title":"Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy","volume":"9","author":"Chin","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftal.2016.02.007_bib0070","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.oftal.2016.02.007_bib0075","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00417-014-2780-6","article-title":"Spironolactone in the treatment of central serous chorioretinopathy - a case series","volume":"252","author":"Herold","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftal.2016.02.007_bib0080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/aos.12392","article-title":"The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy","volume":"92","author":"Breukink","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oftal.2016.02.007_bib0085","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2016.02.007_bib0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1470320314549791","article-title":"Expression of classical components of the renin-angiotensin system in the human eye","volume":"16","author":"White","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.oftal.2016.02.007_bib0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/aos.12482","article-title":"System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy","volume":"92","author":"Ma","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oftal.2016.02.007_bib0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.sjopt.2015.01.007","article-title":"Advances in the treatment of central serous chorioretinopathy","volume":"29","author":"Abouammoh","year":"2015","journal-title":"Saudi J Ophthalmol"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036566911600112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036566911600112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:22:19Z","timestamp":1536884539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036566911600112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S036566911600112X"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2016.02.007","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Espironolactona, alternativa terap\u00e9utica en el tratamiento de la epiteliopat\u00eda difusa cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}